
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Direxion Daily S&P Biotech Bull 3X Shares (ARCA:LABU) through any online brokerage.
There are no as such competitors for Direxion Daily S&P Biotech Bull 3X Shares.
There is no analysis for Direxion Daily S&P Biotech Bull 3X Shares to provide a consensus price target.
The stock price for Direxion Daily S&P Biotech Bull 3X Shares (ARCA: LABU) is $ last updated .
There are no upcoming dividends for Direxion Daily S&P Biotech Bull 3X Shares.
Direxion Daily S&P Biotech Bull 3X Shares does not have any upcoming earnings scheduled.
There is no upcoming split for Direxion Daily S&P Biotech Bull 3X Shares.
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Multi Alternative |
| Fund Inception | May 28, 2015 |
| Managers | Tony Ng Paul Brigandi |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
| Symbol | Name | Share % |
|---|---|---|
| DGCXX | Dreyfus Govt Cash Man ... | 21.6% |
| FTIXX | Gs Financial Square Tr... | 12.2% |
| FGTXX | Goldman Sachs Fin Gov ... | 13.3% |
| MRNA | Moderna Inc | 0.94% |
| ROIV | Roivant Sciences Ltd | 0.89% |
| HALO | Halozyme Therapeutics ... | 0.83% |
| PCVX | Vaxcyte Inc | 0.83% |
| MIRM | Mirum Pharmaceuticals ... | 0.82% |
| GILD | Gilead Sciences Inc | 0.81% |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs